These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31838464)

  • 21. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT.
    Miere A; Querques G; Semoun O; Amoroso F; Zambrowski O; Chapron T; Capuano V; Souied EH
    Retina; 2017 Oct; 37(10):1873-1879. PubMed ID: 28079756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescein Leakage and Optical Coherence Tomography Features of Choroidal Neovascularization Secondary to Pathologic Myopia.
    Battaglia Parodi M; Iacono P; Romano F; Bandello F
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3175-3180. PubMed ID: 30025121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia.
    Rinaldi M; Semeraro F; Chiosi F; Russo A; Romano MR; Savastano MC; dell'Omo R; Costagliola C
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):529-539. PubMed ID: 27680013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence or absence of choroidal hyper-transmission by SD-OCT imaging distinguishes inflammatory from neovascular lesions in myopic eyes.
    Shi X; Cai Y; Luo X; Liang S; Rosenfeld PJ; Li X
    Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):751-758. PubMed ID: 31907643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using optical coherence tomography angiography to guide myopic choroidal neovascularization treatment: a 3-year follow-up study.
    Ueda-Consolvo T; Shibuya N; Oiwake T; Abe S; Numata A; Honda Y; Yanagisawa S; Hayashi A
    Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3295-3303. PubMed ID: 34142188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RELATIONSHIP BETWEEN MYOPIC CHOROIDAL NEOVASCULARIZATION ACTIVITY AND PERFORATING SCLERAL VESSELS IN HIGH MYOPIA.
    Ruiz-Medrano J; Almazan-Alonso E; Flores-Moreno I; Puertas M; García-Zamora M; Ruiz-Moreno JM
    Retina; 2022 Jan; 42(1):204-209. PubMed ID: 34438439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APPLICATION OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY TO ASSESS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Cheng Y; Li Y; Huang X; Qu Y
    Retina; 2019 Apr; 39(4):712-718. PubMed ID: 29256987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term variable outcome of myopic choroidal neovascularization treated with ranibizumab.
    Cohen SY; Nghiem-Buffet S; Grenet T; Dubois L; Ayrault S; Fajnkuchen F; Delahaye-Mazza C; Quentel G; Tadayoni R
    Jpn J Ophthalmol; 2015 Jan; 59(1):36-42. PubMed ID: 25416566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CORRESPONDENCE OF LEAKAGE ON FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS IN DIAGNOSIS AND MONITORING OF MYOPIC CHOROIDAL NEOVASCULARIZATION TREATED WITH BEVACIZUMAB.
    Battaglia Parodi M; Iacono P; Bandello F
    Retina; 2016 Jan; 36(1):104-9. PubMed ID: 26166803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of structural and functional outcome of aflibercept versus ranibizumab in patients with myopic choroidal neovascularization.
    Howaidy A; Eldaly ZH
    Eur J Ophthalmol; 2021 Jan; 31(1):211-217. PubMed ID: 31690105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new treatment algorithm for the management of myopic choroidal neovascularization using intravitreal ranibizumab.
    Iacono P; Parodi MB; Papayannis A; La Spina C; Varano M; Bandello F
    Acta Ophthalmol; 2015 Sep; 93(6):e519-20. PubMed ID: 25828793
    [No Abstract]   [Full Text] [Related]  

  • 32. Fundus Autofluorescence Changes After Ranibizumab Treatment for Subfoveal Choroidal Neovascularization Secondary to Pathologic Myopia.
    Parodi MB; Iacono P; Sacconi R; Iuliano L; Bandello F
    Am J Ophthalmol; 2015 Aug; 160(2):322-327.e2. PubMed ID: 25935099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASSESSING THE ACTIVITY OF MYOPIC CHOROIDAL NEOVASCULARIZATION: Comparison Between Optical Coherence Tomography Angiography and Dye Angiography.
    Li S; Sun L; Zhao X; Huang S; Luo X; Zhang A; Chen C; Wang Z; Liu C; Ding X
    Retina; 2020 Sep; 40(9):1757-1764. PubMed ID: 31652198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PREDICTING LESION SHRINKAGE IN EYES WITH MYOPIC CHOROIDAL NEOVASCULARIZATION FROM FEATURES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Liu J; Song S; Yu X
    Retina; 2022 Sep; 42(9):1665-1672. PubMed ID: 35594547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic algorithm utilising multimodal imaging including optical coherence tomography angiography for the detection of myopic choroidal neovascularisation.
    Bagchi A; Schwartz R; Hykin P; Sivaprasad S
    Eye (Lond); 2019 Jul; 33(7):1111-1118. PubMed ID: 30809019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of anatomical and functional outcomes of treating myopic choroidal neovascularization with bevacizumab or ranibizumab.
    Woronkowicz M; Hamilton R; Lightman S; Zagora S; Tomkins-Netzer O
    Int Ophthalmol; 2023 Oct; 43(10):3499-3507. PubMed ID: 37318668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Tomographic Classification of Myopic Choroidal Neovascularization.
    Pascual-Camps I; Andreu-Fenoll M; Ruiz-Moreno JM; Dolz-Marco R; Gallego-Pinazo R
    Ophthalmic Surg Lasers Imaging Retina; 2018 Oct; 49(10):775-779. PubMed ID: 30395663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative Vascular Density Changes in Choriocapillaris Around CNV After Anti-VEGF Treatment: Dark Halo.
    Rispoli M; Savastano MC; Lumbroso B
    Ophthalmic Surg Lasers Imaging Retina; 2018 Dec; 49(12):918-924. PubMed ID: 30566698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia.
    Lalloum F; Souied EH; Bastuji-Garin S; Puche N; Querques G; Glacet-Bernard A; Coscas G; Soubrane G; Leveziel N
    Retina; 2010 Mar; 30(3):399-406. PubMed ID: 20038864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization.
    Oishi A; Yamashiro K; Tsujikawa A; Ooto S; Tamura H; Nakata I; Miyake M; Yoshimura N
    Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):1-7. PubMed ID: 22527326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.